Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.
Clinical trial NCT05480462 · UNKNOWN
Trial details
- NCT number
- NCT05480462
- Sponsor
- IBSS Biomed S.A.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-12
- Primary completion
- 2024-03-04
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.